Timothy C. Dec - Feb 19, 2025 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
Senior Vice-President & CFO
Signature
/s/ Timothy C. Dec
Stock symbol
SUPN
Transactions as of
Feb 19, 2025
Transactions value $
$0
Form type
4
Date filed
2/21/2025, 04:43 PM
Previous filing
Feb 27, 2024
Next filing
Feb 24, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SUPN Common Stock 8.09K Feb 19, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Employee Stock Option (Right to Buy) Award $0 +40K $0.00 40K Feb 19, 2025 Common Stock 40K $33.52 Direct F2
transaction SUPN Restricted Stock Unit Award $0 +4.5K $0.00 4.5K Feb 19, 2025 Common Stock 4.5K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes an aggregate of 901 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
F2 The option vests in four equal annual installments beginning on February 19, 2026.
F3 Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
F4 These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026.